Libourne – 28 March 2018 – Fermentalg (Euronext – FALG), a French leader in microalgae for nutrition and health, has obtained GRAS status for its algal oils naturally rich in omega-3 and has signed a distribution agreement with STAUBER for the United States and Canada. These achievements represent two new milestones in the company's drive to market the DHA ORIGINS range on the North American market.

DHA ORIGINS 350®, an oil with a natural DHA concentration of 350 mg/g, and DHA ORIGINS 550®, the first algal oil with a minimum natural DHA concentration of 550 mg/g, have obtained Generally Recognized As Safe (GRAS) classification awarded by a panel of US experts. GRAS status allows Fermentalg ORIGINS products to be sold in applications dedicated to human nutrition including baby food.

In addition to obtaining this administrative authorisation, Fermentalg signed a US distribution agreement with STAUBER, a leading North American supplier of speciality ingredients.

Stauber is the preferred ingredient distributor in North America. Serving the nutritional, dietary supplement, functional food & beverage, sports, pet care and pharmaceutical industries since 1969, Stauber offers a variety of ingredients for every application. In addition to quality systems for FSMA and GMP programs, Stauber has been rated #1 for overall performance among USA distributors in the area of Customer Service, On-Time Delivery and Product Quality.

Based in Fullerton, California, the company has logistics facilities on both East and West coasts, enabling it to deliver customer requirements throughout the United States. Since 2015, STAUBER has been a subsidiary of Hawkins, Inc. (Nasdaq – HWKN).

Philippe Lavielle, Fermentalg Chairman and CEO, made the following comments: “After gaining authorisation[1] in Europe for our DHA-rich algal oils and signing the distribution agreement with IMCD Group, we have proved our ability to penetrate the US market and deploy a resolutely global strategy for our products. We look forward to presenting DHA ORIGINS 550® , an innovative addition to our omega-3 rich algal oil range that strengthens Fermentalg's positioning on nutrition and health markets, at the VITAFOODS trade fair in Geneva next May.”

About Fermentalg:

An expert in research and bio-industrial use of microalgae, Fermentalg seeks to provide sustainable solutions and innovative products that contribute towards the creation of natural, healthy and effective products. Our business: development, production and sale of active ingredients extracted from microalgae for the agri-food, health and nutrition sectors. Natural nutritional oils, pigments and antioxidants, as well as specialty proteins, comprise our present and future offering.

Fermentalg shares are listed on Euronext in Paris (FR0011271600 - FALG).

For more information, visit: www.fermentalg.com

     

 

Contact Journalistes :Contact Investisseurs :
ACTUS finance & communication
Alexandra PRISA
Tél. : +33 (0)1 53 67 36 90
aprisa@actus.fr
ACTUS finance & communication
Jérôme FABREGUETTES-LEIB
Tél. : +33 (0)1 53 67 36 78
jfl@actus.fr
 

[1] Novel Food authorisation obtained for DHA ORIGINS 350® in 2015, DHA ORIGINS 550® registered on EU list



Regulated information
News releases under ongoing reporting obligations:
- other releases
Full and original press release in PDF:
https://www.actusnews.com/documents_communiques/ACTUS-0-52522-fermentalg-cp-us-uk-vdf-280318.pdf
Receive by email the next press releases of the company by registering on www.actusnews.com, it′s free


© 2018 ActusNews